Hospital H+ Queretaro
11
1
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ABCDEF Bundle Compliance and ICU Outcomes in Latin America
Role: lead
Hemoglobin Trends as a Predictor of Outcomes in Critically Ill Patients (The TRENT-ICU Study)
Role: lead
Standardization of IMT Dosage (UTIT) in Mechanical Ventilation.
Role: lead
CT-Determined Sarcopenia and Mortality in Critically Ill Cancer Patients
Role: lead
Validation of an Effort-Based Cough Peak Flow Algorithm to Predict Extubation Outcomes
Role: lead
Ultrasound vs. Nasofibroscopy for Evaluating Dysphagia After Extubation in the ICU
Role: lead
Fecal Lactate and Resuscitation Outcomes in Critical Illness
Role: lead
Cost-Effectiveness of Inhaled Sedation Versus Intravenous Propofol in Mechanically Ventilated Critically Ill Adults
Role: lead
Occult Vasoplegia in Normotensive Sepsis: Early Prediction With Diastolic Index and Lactate
Role: lead
Frailty and Severity as Determinants of Hospital Cost in the ICU
Role: lead
Incidence of Invasive Aspergillosis and Its Relation to Galactomannan Clinical Outcomes
Role: lead
All 11 trials loaded